Manager I, R2R Operations at Bristol-Myers Squibb

Hyderabad, Telangana, India

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

R2RRecord-to-ReportAccounting ProcessesFinanceLeadershipControllership

Questions & Answers

Common questions about this position

What is the location and work arrangement for this role?

The position is based in BMS’s Hyderabad Location with an expected 50% in-person requirement.

What experience level is required for this position?

A minimum of 5-7 years of experience is required.

What are the key skills needed for the Controllership R2R Ops Manager role?

Candidates need exceptional expertise in record-to-report accounting processes, deep understanding of the business landscape, market trends, and industry dynamics, excellent leadership skills, and open communication abilities.

What is the company culture like at Bristol Myers Squibb?

BMS offers a challenging, meaningful, and life-changing work environment with high-achieving teams, opportunities for growth, and a focus on balance and flexibility.

Are there any application tips for this role?

If the role intrigues you but doesn’t perfectly match your resume, BMS encourages you to apply anyway.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI